Oppenheimer Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,038	Closed	-$258K	–	1140
2024 Q4	$258K	Buy	5,038 +822	+19%	+$42K	﹤0.01%	1018
2024 Q3	$215K	Buy	+4,216	New	+$215K	﹤0.01%	1082
2024 Q2	–	Sell	-4,276	Closed	-$200K	–	1156
2024 Q1	$200K	Buy	+4,276	New	+$200K	﹤0.01%	1039